
HER2 - Wikipedia
Receptor tyrosine-protein kinase erbB-2 is a protein that normally resides in the membranes of cells and is encoded by the ERBB2 gene. ERBB is abbreviated from erythroblastic oncogene …
ERBB2 Gene - GeneCards | ERBB2 Protein | ERBB2 Antibody
Mar 30, 2025 · ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with ERBB2 include Visceral Neuropathy, Familial, 2, Autosomal Recessive and …
ErbB - Wikipedia
In humans, the family includes Her1 (EGFR, ErbB1), Her2 (ErbB2), Her3 (ErbB3), and Her4 (ErbB4). The gene symbol, ErbB, is derived from the name of a viral oncogene to which these …
ERBB2 - My Cancer Genome
ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2, also known as HER2 and neu) is a gene that encodes for the receptor tyrosine-protein kinase erbB-2. ERBB2 has …
Emergence of ERBB2 Mutation as a Biomarker and an Actionable …
ERBB2 amplification is an established therapeutic target in breast and gastric cancers, but efforts to translate this finding to other solid tumors with ERBB2 amplification have not been effective. …
ERBB2 erb-b2 receptor tyrosine kinase 2 [ (human)]
ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis. ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human …
Molecular Mechanisms of ErbB2-Mediated Breast Cancer …
The erbB2 (also known as HER2 or neu) gene encodes a 185-kDa transmembrane glycoprotein, which belongs to the epidermal growth factor receptor (EGFR) family. ErbB2 is a receptor …
ERBB1 and ERBB2 have distinct functions in tumor cell invasion …
The EGF receptor (ERBB1) and related family member HER2/neu (ERBB2) are often overexpressed in aggressive breast cancers and their overexpression is correlated with poor …
Diverse ERBB2/ERBB3 Activating Alterations And Co-Alterations …
Apr 3, 2025 · ERBB2/ERBB3 Amplification Pan-Tumor Landscape The distribution of amplification ratios for tumors with a) ERBB2 and b) ERBB3 amplification in tissue biopsies as assessed by …
Activating Mutations in ERBB2 and Their Impact on Diagnostics …
ERBB2/HER2, best known for its role in breast cancer tumorigenesis, can be targeted by two types of pharmacological manipulation: antibody therapy against the extracellular receptor …